A Homecoming: dsm-firmenich Expands Listing to SIX Swiss Exchange

The primary listing marks a further strengthening of the company’s presence in the Swiss capital market. No new shares were issued as part of the transaction, with all existing shares admitted to trading and fully fungible between trading venues.

The move reflects both dsm-firmenich’s strong Swiss roots and the continued relevance of Switzerland as a hub for global companies seeking access to international investors. Operating across nutrition, health and beauty, the company combines more than 150 years of scientific heritage and serves customers in industries ranging from food and beverages to consumer goods and pharmaceuticals.

Against a backdrop of evolving capital markets, the listing highlights the role of SIX Swiss Exchange in connecting international issuers with a highly sophisticated investor base, offering strong liquidity, visibility through leading indices and a stable market environment.

Dimitri de Vreeze, CEO of dsm-firmenich, commented: “Our listing on SIX Swiss Exchange marks an important milestone for dsm-firmenich, and further enhances our positioning with Swiss and international investors. Alongside our listing on Euronext Amsterdam, this new trading venue expands access to capital and reinforces our presence across key European equity markets. We expect this to support the continued development of a diverse, high-quality shareholder base and long-term value creation.”